Header Logo

Connection

Faeezah Patel to Humans

Back to Details
This is a "connection" page, showing publications Faeezah Patel has written about Humans.
Faeezah Patel
Connection Strength
0,719
Humans
  1. HIV treatment success in children and adolescents with HIV. Lancet HIV. 2022 08; 9(8):e526-e527.
    View in: PubMed
    Score: 0,062
  2. Low Pretreatment Viral Loads in Infants With HIV in an Era of High-maternal Antiretroviral Therapy Coverage. Pediatr Infect Dis J. 2021 01; 40(1):55-59.
    View in: PubMed
    Score: 0,055
  3. Negative Diagnostic PCR Tests in School-Aged, HIV-Infected Children on Antiretroviral Therapy Since Early Life in Johannesburg, South Africa. J Acquir Immune Defic Syndr. 2020 04 01; 83(4):381-389.
    View in: PubMed
    Score: 0,053
  4. Immunogenicity and safety of SARS-CoV-2 recombinant spike protein vaccine in South African people living with and without HIV-1 infection: A phase 2 randomised trial. J Infect. 2024 Dec; 89(6):106285.
    View in: PubMed
    Score: 0,018
  5. Growth Trajectories Over the First Year of Life Among Early-Treated Infants with Human Immunodeficiency Virus and Infants Who are Human Immunodeficiency Virus-Exposed Uninfected. J Pediatr. 2024 Jul; 270:114018.
    View in: PubMed
    Score: 0,017
  6. Pharmacokinetics, safety, and tolerability of dispersible and immediate-release abacavir, dolutegravir, and lamivudine tablets in children with HIV (IMPAACT 2019): week 24 results of an open-label, multicentre, phase 1-2 dose-confirmation study. Lancet HIV. 2023 08; 10(8):e506-e517.
    View in: PubMed
    Score: 0,017
  7. Microbiota in the oral cavity of school-age children with HIV who started antiretroviral therapy at young ages in South Africa. AIDS. 2023 08 01; 37(10):1583-1591.
    View in: PubMed
    Score: 0,016
  8. Efficacy and safety of three antiretroviral therapy regimens started in pregnancy up to 50 weeks post partum: a multicentre, open-label, randomised, controlled, phase 3 trial. Lancet HIV. 2023 06; 10(6):e363-e374.
    View in: PubMed
    Score: 0,016
  9. Efficacy of primary series AZD1222 (ChAdOx1 nCoV-19) vaccination against SARS-CoV-2 variants of concern: Final analysis of a randomized, placebo-controlled, phase 1b/2 study in South African adults (COV005). Vaccine. 2023 05 26; 41(23):3486-3492.
    View in: PubMed
    Score: 0,016
  10. High prevalence of SARS-CoV-2 antibodies in pregnant women after the second wave of infections in the inner-city of Johannesburg, Gauteng Province, South Africa. Int J Infect Dis. 2022 Dec; 125:241-249.
    View in: PubMed
    Score: 0,016
  11. T-cell responses induced by ChAdOx1 nCoV-19 (AZD1222) vaccine to wild-type severe acute respiratory syndrome coronavirus 2 among people with and without HIV in South Africa. AIDS. 2023 01 01; 37(1):105-112.
    View in: PubMed
    Score: 0,016
  12. Durability of ChAdOx1 nCoV-19 (AZD1222) vaccine and hybrid humoral immunity against variants including omicron BA.1 and BA.4 6 months after vaccination (COV005): a post-hoc analysis of a randomised, phase 1b-2a trial. Lancet Infect Dis. 2023 03; 23(3):295-306.
    View in: PubMed
    Score: 0,016
  13. Comparison of quantitative ultrasonography and dual X-ray absorptiometry for bone status assessment in South African children living with HIV. PLoS One. 2022; 17(10):e0276290.
    View in: PubMed
    Score: 0,016
  14. Predictors of Cell-Associated Human Immunodeficiency Virus (HIV)-1 DNA Over 1 Year in Very Early Treated Infants. Clin Infect Dis. 2022 03 23; 74(6):1047-1054.
    View in: PubMed
    Score: 0,015
  15. Persistently lower bone mass and bone turnover among South African children living with well controlled HIV. AIDS. 2021 11 01; 35(13):2137-2147.
    View in: PubMed
    Score: 0,015
  16. Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in people living with and without HIV in South Africa: an interim analysis of a randomised, double-blind, placebo-controlled, phase 1B/2A trial. Lancet HIV. 2021 09; 8(9):e568-e580.
    View in: PubMed
    Score: 0,014
  17. Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant. N Engl J Med. 2021 05 20; 384(20):1885-1898.
    View in: PubMed
    Score: 0,014
  18. Switch to Efavirenz Attenuates Lipoatrophy in Girls With Perinatal HIV. J Pediatr Gastroenterol Nutr. 2021 01 01; 72(1):e15-e20.
    View in: PubMed
    Score: 0,014
  19. COVID-19 in pregnancy in South Africa: Tracking the epidemic and defining the natural history. S Afr Med J. 2020 07 30; 110(8):729-731.
    View in: PubMed
    Score: 0,013
  20. Deficits in Bone Architecture and Strength in Children Living With HIV on Antiretroviral Therapy. J Acquir Immune Defic Syndr. 2020 05 01; 84(1):101-106.
    View in: PubMed
    Score: 0,013
  21. HIV diagnostic challenges in breast-fed infants of mothers on antiretroviral therapy. AIDS. 2019 09 01; 33(11):1751-1756.
    View in: PubMed
    Score: 0,013
  22. Bone Quality Measured Using Calcaneal Quantitative Ultrasonography Is Reduced Among Children with HIV in Johannesburg, South Africa. J Pediatr. 2019 12; 215:267-271.e2.
    View in: PubMed
    Score: 0,013
  23. Distinct epigenetic profiles in children with perinatally-acquired HIV on antiretroviral therapy. Sci Rep. 2019 07 19; 9(1):10495.
    View in: PubMed
    Score: 0,013
  24. Mitochondrial Impairment in Well-Suppressed Children with Perinatal HIV-Infection on Antiretroviral Therapy. AIDS Res Hum Retroviruses. 2020 01; 36(1):27-38.
    View in: PubMed
    Score: 0,013
  25. Educational delays among children living with perinatally-acquired HIV in Johannesburg, South Africa. AIDS Care. 2020 04; 32(4):438-444.
    View in: PubMed
    Score: 0,013
  26. Early infant diagnosis HIV-1 PCR cycle-threshold predicts infant viral load at birth. J Clin Virol. 2019 05; 114:21-25.
    View in: PubMed
    Score: 0,012
  27. 12-month outcomes of HIV-infected infants identified at birth at one maternity site in Johannesburg, South Africa: an observational cohort study. Lancet HIV. 2018 12; 5(12):e706-e714.
    View in: PubMed
    Score: 0,012
  28. Substituting Abacavir for Stavudine in Children Who Are Virally Suppressed Without Lipodystrophy: Randomized Clinical Trial in Johannesburg, South Africa. J Pediatric Infect Dis Soc. 2018 Aug 17; 7(3):e70-e77.
    View in: PubMed
    Score: 0,012
  29. Biomarkers of Aging in HIV-Infected Children on Suppressive Antiretroviral Therapy. J Acquir Immune Defic Syndr. 2018 08 15; 78(5):549-556.
    View in: PubMed
    Score: 0,012
  30. Patterns of Growth, Body Composition, and Lipid Profiles in a South African Cohort of Human Immunodeficiency Virus-Infected and Uninfected Children: A Cross-Sectional Study. J Pediatric Infect Dis Soc. 2018 May 15; 7(2):143-150.
    View in: PubMed
    Score: 0,012
  31. Age at antiretroviral therapy initiation and cell-associated HIV-1 DNA levels in HIV-1-infected children. PLoS One. 2018; 13(4):e0195514.
    View in: PubMed
    Score: 0,011
  32. Decreased bone turnover in HIV-infected children on antiretroviral therapy. Arch Osteoporos. 2018 Apr 05; 13(1):40.
    View in: PubMed
    Score: 0,011
  33. Reply to Van de Wijer et al. Clin Infect Dis. 2018 03 19; 66(7):1151-1152.
    View in: PubMed
    Score: 0,011
  34. Dietary Inadequacies in HIV-infected and Uninfected School-aged Children in Johannesburg, South Africa. J Pediatr Gastroenterol Nutr. 2017 09; 65(3):332-337.
    View in: PubMed
    Score: 0,011
  35. Prevalence and outcomes of HIV-1 diagnostic challenges during universal birth testing - an urban South African observational cohort. J Int AIDS Soc. 2017 08 29; 20(Suppl 6):21761.
    View in: PubMed
    Score: 0,011
  36. Switching to Efavirenz Versus Remaining on Ritonavir-boosted Lopinavir in Human Immunodeficiency Virus-infected Children Exposed to Nevirapine: Long-term Outcomes of a Randomized Trial. Clin Infect Dis. 2017 Aug 01; 65(3):477-485.
    View in: PubMed
    Score: 0,011
  37. Early age at start of antiretroviral therapy associated with better virologic control after initial suppression in HIV-infected infants. AIDS. 2017 Jan 28; 31(3):355-364.
    View in: PubMed
    Score: 0,011
  38. Effect of Lopinavir and Nevirapine Concentrations on Viral Outcomes in Protease Inhibitor-experienced HIV-infected Children. Pediatr Infect Dis J. 2016 12; 35(12):e378-e383.
    View in: PubMed
    Score: 0,010
  39. Efavirenz is associated with higher bone mass in South African children with HIV. AIDS. 2016 10 23; 30(16):2459-2467.
    View in: PubMed
    Score: 0,010
  40. Unusually High Calcaneal Speed of Sound Measurements in Children with Small Foot Size. Ultrasound Med Biol. 2017 01; 43(1):357-361.
    View in: PubMed
    Score: 0,010
  41. Extent of disclosure: what perinatally HIV-infected children have been told about their own HIV status. AIDS Care. 2017 03; 29(3):378-386.
    View in: PubMed
    Score: 0,010
  42. Decreased Vigorous Physical Activity in School-Aged Children with Human Immunodeficiency Virus in Johannesburg, South Africa. J Pediatr. 2016 05; 172:103-9.
    View in: PubMed
    Score: 0,010
  43. Case report: Severe central nervous system manifestations associated with aberrant efavirenz metabolism in children: the role of CYP2B6 genetic variation. BMC Infect Dis. 2016 Feb 02; 16:56.
    View in: PubMed
    Score: 0,010
  44. Efavirenz-Based Antiretroviral Therapy Among Nevirapine-Exposed HIV-Infected Children in South Africa: A Randomized Clinical Trial. JAMA. 2015 Nov 03; 314(17):1808-17.
    View in: PubMed
    Score: 0,010
  45. Initiation of antiretroviral therapy before 6 months of age is associated with faster growth recovery in South African children perinatally infected with human immunodeficiency virus. J Pediatr. 2013 Jun; 162(6):1138-45, 1145.e1-2.
    View in: PubMed
    Score: 0,008
  46. Metabolic abnormalities and body composition of HIV-infected children on Lopinavir or Nevirapine-based antiretroviral therapy. Arch Dis Child. 2013 Apr; 98(4):258-64.
    View in: PubMed
    Score: 0,008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.